Related Experiment Video

Updated: Sep 29, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.1K

Recent Development of Prodrugs of Gemcitabine

Bhoomika Pandit1, Maksim Royzen1

  • 1Department of Chemistry, University at Albany, 1400 Washington Ave., Albany, NY 12222, USA.

Genes
|March 25, 2022
PubMed

Insights

Gemcitabine is an anticancer drug with limited efficacy due to deactivation and resistance. This review explores novel prodrug and delivery strategies to improve gemcitabine

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Delivery

Background:

  • Gemcitabine is a widely used nucleoside analog for treating various cancers.
  • Its clinical efficacy is limited by rapid clearance, enzymatic deamination, and chemoresistance.
  • Novel prodrug and drug delivery strategies are being developed to overcome these limitations.

Purpose of the Study:

  • To review recent advancements in gemcitabine prodrugs.
  • To evaluate the effectiveness of novel gemcitabine formulations in cancer treatment.
  • To highlight strategies for improving gemcitabine's pharmacokinetic properties, efficacy, and safety.

Main Methods:

  • Literature review of recent studies on gemcitabine prodrugs and delivery systems.
  • Analysis of research on overcoming gemcitabine resistance mechanisms.
  • Evaluation of preclinical and clinical data on novel gemcitabine formulations.

Main Results:

  • Various prodrug strategies have shown potential in enhancing gemcitabine's pharmacokinetic profile.
  • Targeted drug delivery systems aim to improve gemcitabine's efficacy and reduce systemic toxicity.
  • Emerging prodrugs and delivery methods demonstrate promise in preclinical cancer models.

Conclusions:

  • Prodrug and targeted delivery approaches represent promising strategies to enhance gemcitabine's therapeutic index.
  • Further research is needed to translate these advancements into effective clinical treatments.
  • Optimizing gemcitabine delivery is crucial for improving outcomes in various cancer types.
Keywords:
anticancer agentchemotherapydrug deliverygemcitabineprodrug

More Related Videos

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

1.2K
Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment09:56

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

Published on: April 30, 2019

9.3K

Related Concept Videos

Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.2K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.3K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.0K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K